[Lymphoscintigraphy with 99mTc-DTPA-HSA in the diagnosis of protein-losing gastroenteropathy].
We evaluated the diagnostic capability of technetium-99m-diethylene triamine pentaacetic acid-human serum albumin (99mTc-DTPA-HSA) lymphoscintigrapy in a patient with protein-losing gastroenteropathy. 99mTc-DTPA-HSA (total 740 MBq) was injected subcutaneously into the digital webs of the both feet. With a gamma camera, whole-body and abdominal lymphoscintigrams were obtained after the injection of the radioisotope: early images and delayed images taken 5-15 min and 50-60 min, respectively, after the injection. A few days later, the dynamic lymphoscintigraphy was also performed. Lymph fluid leakage into the small bowel and the sites of the leakage were detected. It was concluded that lymphoscintigraphy with 99mTc-DTPA-HSA was a useful diagnostic tool in patients with protein-losing gastroenteropathy.
Kikuchi
M
M
Department of Radiology, Iwate Medical University.
Takahashi
T
T
Kato
K
K
Oikawa
H
H
Obara
T
T
Yanagisawa
T
T
Katayama
S
S
Sato
S
S
D000328:Adult; D005260:Female; D006801:Humans; D061305:Lymphoscintigraphy; D011504:Protein-Losing Enteropathies / Q000000981:diagnostic imaging*; D013668:Technetium Tc 99m Aggregated Albumin; D016284:Technetium Tc 99m Pentetate
D013668:Technetium Tc 99m Aggregated Albumin; C057162:technetium Tc 99m DTPA HSA; D016284:Technetium Tc 99m Pentetate